Type 2 Diabetes
Conditions
Keywords
plant-based, vegan, diet, obesity
Brief summary
This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Data will also be analyzed to see if participation in the program results in reductions glycated hemoglobin levels, body weight, and cholesterol levels.
Detailed description
This study aims to assess the feasibility and implementation of an online, plant-based, diabetes reversal program in a community setting. The study will also assess changes in glycated hemoglobin, body weight, and plasma lipids with an online 12-week, plant-based, nutrition education program. These health benefits may illustrate feasibility to physicians and healthcare professionals elsewhere, in addition to their value for the individual research participants.
Interventions
BEHAVIORALplant-based diet
For the duration of the study, this arm will: follow a low-fat vegan diet; weigh themselves weekly, and get fasting bloodwork before, during and after the study
Sponsors
Physicians Committee for Responsible Medicine
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
single group, multiple replications
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* U.S. Men and women meeting the age of majority, defined as follows: Age 19 or older in Nebraska and Alabama; Age 21 or older in Mississippi; Age 18 or older in all other states * Prior diagnosis of type 2 diabetes mellitus
Exclusion criteria
* Use of recreational drugs in the past 6 months * Pregnancy or intention to become pregnant during the study period, as verified by self-report * Unstable medical or psychiatric illness * Lack of English fluency * Inability to maintain current medication regimen * Inability or unwillingness to participate in all components of the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Glycated hemoglobin | 12 weeks | A1c will be measured before and after the study period |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| body weight | 12 weeks | participants will track body weight weekly using a RNFO scale |
| total cholesterol | 12 weeks | total cholesterol will be measured before and after the study period |
| LDL cholesterol | 12 weeks | LDL cholesterol will be measured before and after the study period |
| medication usage | 12 weeks | changes in medications to treat diabetes will be tracked during the study period |
Countries
United States
Contacts
Primary ContactVANITA RAHMAN, MD
Backup ContactRoxanne Becker, MBChB
Outcome results
None listed